The chemical class designated as SLC4A8 Activators encompasses a variety of compounds that, while not directly interacting with the SLC4A8 protein, can facilitate an increase in its activity through indirect mechanisms within cellular biochemical pathways. This activation may result from a range of effects, from transcriptional regulation to post-translational modifications and alterations in the cellular environment that favor the transporter's function. For instance, agents that lead to elevated intracellular cyclic AMP (cAMP) levels, such as forskolin and dibutyryl-cAMP, can initiate a cascade of intracellular events culminating in the enhanced transcription of the SLC4A8 gene or greater transporter density at the cell membrane. Hormonal agents, like hydrocortisone and estrogen, might interact with their respective receptors to induce expression changes in SLC4A8, while growth factors such as EGF can stimulate pathways leading to the increased presence of the transporter protein on the plasma membrane.
Beyond transcriptional modulation, the operational activity of SLC4A8 is sensitive to the cellular ionic milieu, as demonstrated by zinc sulfate, which may stabilize the transporter structure or influence its ion transport efficacy. Similarly, ionophores like ionomycin can perturb intracellular calcium levels, potentially leading to a secondary upregulation of SLC4A8 activity as the cell works to reestablish homeostasis. The influence of intracellular redox states on transporter activity is also notable, with NAD+ being a key player in redox reactions and, conceivably, in the modulation of SLC4A8. Collectively, these activators constitute a diverse but functionally synergistic chemical class, each member contributing to the heightened activity of SLC4A8 through a unique but converging action within the complex web of cellular biochemistry.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, possibly enhancing SLC4A8 gene transcription. | ||||||
3,5-Diiodo-L-thyronine | 1041-01-6 | sc-216601 sc-216601A sc-216601B sc-216601C sc-216601D | 1 g 5 g 10 g 25 g 100 g | $270.00 $562.00 $938.00 $1408.00 $2673.00 | 2 | |
May upregulate SLC4A8 through thyroid hormone-responsive elements. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc can modulate transporter activity and might stabilize SLC4A8 protein. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
May upregulate SLC4A8 expression via glucocorticoid response elements. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Through estrogen receptors, it can influence SLC4A8 expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
May promote SLC4A8 translocation to the membrane via PI3K/Akt signaling. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can increase expression of SLC4A8. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which could upregulate SLC4A8. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that may indirectly enhance SLC4A8 function. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
May influence SLC4A8 activity via cellular redox states. | ||||||